4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000208
Director sold 3,080 shares at $27.07 ($83,376)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-01 | Sale : show line 1 in the form 10b5-1 | −3,080 | $27.07 | $83,376 | 112,076 | D |
| Open-market sales · 3,080 sh · avg $27.07 · $83,376 | ||||||
Loading xslF345X05/wk-form4_1730841680.xml…